Funding accounted for 34.5 percent of total financial assistance requested in campaigns initiated between Jan. 1, 2021, and Feb. 28, 2023.

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.

Results of the CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in renal cell carcinoma, were presented at JADPRO 2025.

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

Investigators presented initial results from the phase 3 RAMPART trial of adjuvant durvalumab monotherapy or combined with tremelimumab for resected primary renal cell carcinoma.

Researchers assessed the effectiveness of a modified SUNTRAC to identify risk of skin cancer in solid organ transplant recipients.

Exerkines, the molecular signals released through physical exertion, may be protective against radiation toxicities for patients with prostate cancer.

Increase seen in overall survival, especially among those with HER2+-positive cancers, with median increase of more than 10 months.

Oncology care gaps are more pronounced among rural populations, and in counties with higher levels of cancer mortality, health risks, and socioeconomic risks, researchers reported.

Given that only about 1 in 4 eligible individuals currently receive housing assistance, a potential benefit of extending housing assistance may be earlier-stage diagnoses of these cancers,” ...